A randomised study to compare the effectiveness of hyoscine hydrobromide (Hyoscine) and glycopyrronium (Robinul) in the management of noisy breathing/retained secretions in cancer patients

ISRCTN ISRCTN87058979
DOI https://doi.org/10.1186/ISRCTN87058979
Protocol serial number N0258107515
Sponsor Department of Health (UK)
Funder The Royal Marsden NHS Foundation Trust (UK) Charitable Funds
Submission date
12/09/2003
Registration date
12/09/2003
Last edited
04/01/2016
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Janet Hardy
Scientific

c/o Palliative Care
Mater Adult Hospital
Raymond Terrace
South Brisbane
Qld 4101
Australia

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleA randomised study to compare the effectiveness of hyoscine hydrobromide (Hyoscine) and glycopyrronium (Robinul) in the management of noisy breathing/retained secretions in cancer patients
Study objectives1. To compare the effectiveness of both hyoscine hydrobromide and glycopyrronium at relieving retained secretions at the time of death.
2. To test feasibility of the advanced 'consent process'.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCancer: Noisy breathing, retained secretions
InterventionRandomised test intervention versus standardised intervention, non-blinded (Phase 3).
Intervention typeDrug
PhasePhase III
Drug / device / biological / vaccine name(s)Hyoscine hydrobromide, glycopyrronium
Primary outcome measure(s)

1. Provide an evidence base for common practice
2. Provide a means of obtaining consent for research in dying patients

Key secondary outcome measure(s)

Not provided at time of registration

Completion date28/02/2005

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target sample size at registration205
Key inclusion criteriaTotal number of Royal Marsden Hospital patients 205
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment28/02/2002
Date of final enrolment28/02/2005

Locations

Countries of recruitment

  • United Kingdom
  • Australia

Study participating centre

Mater Adult Hospital
South Brisbane
Qld 4101
Australia

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

07/12/2015: no publications found on PubMed.
04/01/2016: this study was abandoned in 2003.